samedan logo
 
 
spacer
home > pmps > autumn 2019 > industry insight
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Industry Insight





As a CEO of a small entrepreneurial company, I can speak from experience in dealing with other businesses internationally and across borders. This is fitting as it ties in well with the Asian pharma market focus topic in this issue of PMPS; during my professional career, I have had experience in dealing with not only the Asian market, but also the European market and the US, and their methodologies seem to be different.

In my company, we create and develop new small molecule therapeutics, prove them out, protect them with IP, and then we look to third parties to either license or acquire our projects for commercialisation.
 

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer

Print this page
Send to a friend
Privacy statement
News and Press Releases

Winners of the 2021 CPhI Pharma Awards have now been announced

Milan, 10 November 2021: CPhI Worldwide announces the winners of the 18th edition of the CPhI Pharma Awards, hosted live in Milan, with winners spanning some 10 distinct categories. The Awards seek to recognise ‘Excellence in Pharma’ , assessing entries from the industry leading companies and individuals.
More info >>

White Papers

Convergence in the Pharmaceutical Market

PCI Pharma Services

Convergence is currently playing a large part in the growth of the pharmaceutical market. The need for convergence is due to many factors including the declining economy and high competition within the sector. There are many convergences within this sector to date; these include the convergence of food based products with medical and health products and the convergence of prescription drugs to over the counter (OTC) products. Although convergence is helping the pharmaceutical industry expand and develop, it also poses some challenges; these include the regulatory outlook and counterfeiting.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement